Is LBRX up or down today?
LBRX is down 3.50% today, last at 44.63. This stock moved -3.50% versus the prior close.
LBRX · LBRX
LBRX (LBRX) is trading at 44.63, down 3.50% on the session. LBRX sits at the 85% mark of its 52-week range, carries a 14-day RSI of 46, and trades above its 50-day average. Over the past month it is down 1.65%.
Leading the coverage: “LB Pharmaceuticals (NASDAQ: LBRX) Names Joseph M. Miller as CFO with $530K Salary and 200,000-Share Stock Option - Kalkine Media” (Google News Company, 8d ago). LBRX is -9.55% since story.
LBRX trades on a trailing P/E of 9.1 and is running 0.59% behind the S&P 500 over the same stretch.
Analyst firms are mostly reiterating — no strong directional shift lately.
LBRX is down 3.50% today, last at 44.63. This stock moved -3.50% versus the prior close.
Leading the coverage: “LB Pharmaceuticals (NASDAQ: LBRX) Names Joseph M. Miller as CFO with $530K Salary and 200,000-Share Stock Option - Kalkine Media” (Google News Company, 8d ago). LBRX is -9.55% since story. Dominant story: Bank of America Corp DE Has $410,000 Stock Position in LB Pharmaceuticals Inc $LBRX - MarketBeat (1 source, bullish) RSI is 46 — neutral Price above 50-day average — short-term uptrend Social sentiment loads separately — see the Social tab.
Analyst firms are mostly reiterating — no strong directional shift lately.
Loaded: Mar 2026 – Sep 2026 (125 days) · Drag or scroll left for earlier dates
Bank of America Corp DE Has $410,000 Stock Position in LB Pharmaceuticals Inc $LBRX - MarketBeat
IPO Stock LB Pharma Has Tripled In Under A Year. Is It A Takeover Target?
Bank of New York Mellon Corp Makes New $1.78 Million Investment in LB Pharmaceuticals Inc $LBRX - MarketBeat
LB Pharmaceuticals (NASDAQ: LBRX) Names Joseph M. Miller as CFO with $530K Salary and 200,000-Share Stock Option - Kalkine Media
2 Reasons LB Pharmaceuticals (LBRX) Looks Pricey Following Its CFO Appointment